Nuvation Bio enters $250M convertible note deal.
Nuvation Bio agreed to sell $250 million of 0.75% convertible senior notes due 2032. This financing agreement was negotiated with Jefferies, Citigroup, and Cantor Fitzgerald as underwriters.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day